Open AccessUmbilical cord tissue-derived mesenchymal stem cells should be considered as adjuvant therapy for COVID-19 treatment: An opinion from pooled clinical evidence
Author(s) -
Ngoc Bich Vu,
Van Phuc Pham
Publication year - 2021
Publication title -
biomedical research and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 1
ISSN - 2198-4093
DOI - 10.15419/bmrat.v8i9.694
Subject(s) - umbilical cord , medicine , mesenchymal stem cell , clinical trial , transplantation , randomized controlled trial , adjuvant , adjuvant therapy , covid-19 , stem cell , surgery , intensive care medicine , immunology , pathology , disease , chemotherapy , biology , infectious disease (medical specialty) , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom